Sakra Hospital Expands: Second Bengaluru Facility at Rs 1,000 Crore

Sakra World Hospital, a joint venture between SECOM and Toyota Tsusho Corporation (TTC), has announced plans to establish a healthcare facility in Banaswadi, Bengaluru, with an expected investment of Rs 1,000 crore.

Modi Removes Constitutional Barriers, Improves J&K Healthcare: Dr. Jitendra

Union Minister Dr Jitendra Singh recently addressed the “Doctors’ Sammelan” organized by BJP, where he shared his perspective on the challenges faced by the healthcare sector in Jammu & Kashmir.

US Business Growth Boosts Pharma Companies

For the past eighteen months, Gujarat's pharmaceutical companies have been grappling with concerns over price erosion in the US market. However, recent developments indicate a welcome resurgence in their US market revenues.

Transgender Healthcare Monitoring Committee Formed by BMC

The Brihanmumbai Municipal Corporation (BMC) has set up a ten-member committee to monitor the healthcare facilities and challenges faced by the transgender population in civic-run hospitals.

Drug Quality Failures Linked to Political Bond Donations

Recent data released by the Indian Election Commission on March 14 reveals that around 35 pharmaceutical companies in India have contributed approximately Rs 1,000 crore to political parties through electoral bonds.

DTAB Recommends Nimesulide Study: Bans Veterinary Use

The Drugs Technical Advisory Board (DTAB) recently held a meeting in January. The discussion revolved around prohibiting veterinary use of nonsteroidal anti-inflammatory drug (NSAID) Nimesulide formulations for vulture conservation.

WHO & UNICEF Unveil online course to address children's environmental health

Understanding the pressing need to engage all healthcare providers to protect kids' well-being amid the difficulties of ecological contamination and environmental change.

Sibylla Signs Drug Discovery Pact with Ono Pharma For Multiple Therapeutics

Sibylla Biotech declared a drug discovery joint pact with Osaka-settled Ono pharma for getting to Sibylla's state of the art Pharmacological Protein Inactivation by Folding Intermediates Targeting (PPI-FIT) innovation to distinguish and foster...

Bayer and Aignostics to Partner on next-gen Precision Oncology

Bayer and Aignostics GmbH declared an strategic partnership on artificial intelligence (AI)- fueled approaches with applications in precision oncology drug innovative work. Aignostics is a side project from one of the world's driving medical...

Eris Lifesciences Buys Biocon Biologics For Rs 1,242 crore

Eris Lifesciences declared the acquisition of Biocon Biologics' India-marked detailing business for Rs. 1,242 crore. Eris has likewise marked a 10-year supply concurrence with Biocon Biologics on account of this agreement...

© 2024 India Pharma Outlook. All Rights Reserved.